Drusco A, P Fadda, Nigita G, Fassan M, Bottoni A, Gardiman Mp, D Sacchi, Calore F, Carosi M, Antenucci A, B Casini, Kelani H, Pescarmona E, Di Leva G, Zanesi N, Berger Ms, Croce Cm
The World Health Organization has recently introduced molecular prognostic-diagnostic biomarkers in the classification of Central Nervous System (CNS) tumors. In order to characterize subclasses of tumors that cannot find a precise location in the current classification, and, or cannot be tested because of scant material, it is important to find new molecular biomarkers in tissue and, or biological fluid samples. In this study, we identified serum microRNAs that could serve as biomarkers for the diagnosis and prognosis of patients with tumors of glial origin...
March 21, 2018: EBioMedicine